TCWM
GYRE icon

Total Clarity Wealth Management’s Gyre Therapeutics GYRE Stock Holding History

Total Clarity Wealth Management’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-267
Closed -$8K – 1010
2021
Q3 		$8K Buy
+267
New +$8.79K ﹤0.01% 731

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Total Clarity Wealth Management's GYRE Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of Gyre Therapeutics (GYRE) in Q4 2021, closing a stake of 267 shares — an estimated $8K sold.

Total Clarity Wealth Management first reported a position in GYRE in Q3 2021 and held it in 1 quarter. The position peaked at $8K in Q3 2021. 51 funds tracked by Wall St. Rank hold GYRE as of Q4 2021.

  • Total Clarity Wealth Management reported no remaining Gyre Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 267 Gyre Therapeutics shares in Q4 2021, an estimated $8K.
  • Total Clarity Wealth Management first reported a position in Gyre Therapeutics in Q3 2021 and held it in 1 quarter.
  • Total Clarity Wealth Management's Gyre Therapeutics position peaked at $8K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.